MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

Core Points - The Lead Plaintiff Deadline for the securities class action lawsuit against MoonLake Immunotherapeutics is December 15, 2025 [1] - The lawsuit claims that MoonLake and certain executives made materially false and misleading statements about the clinical prospects of their lead drug candidate, sonelokimab (SLK) [1] - The alleged misleading statements resulted in a significant stock price decline for MoonLake [1]